Profactor Pharma Ltd
Operator of a biotechnology company intended to manufacture low-cost recombinant FVIII and transform the treatment of 'Haemophilia A'. The company offers innovative treatment by developing recombinant blood factors, enabling healthcare institutions to get access to an enhanced procedure to treat hemophilia.
1
Funding Rounds
$2.5m
Money raised
Overview
Operator of a biotechnology company intended to manufacture low-cost recombinant FVIII and transform the treatment of 'Haemophilia A'. The company offers innovative treatment by developing recombinant blood factors, enabling healthcare institutions to get access to an enhanced procedure to treat hemophilia.
- Website:
- Headquarters: Edinburgh
- Social accounts: linkedin
Funding series
Funding Series Analysis
The company Profactor Pharma Ltd has raised a total of $2.45m in funding over 1 rounds.
Key Insights:
- Profactor Pharma Ltd , September 2019: $2.45m
Profactor Pharma Ltd , September 2019
$2.45m